AU4326197A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU4326197A
AU4326197A AU43261/97A AU4326197A AU4326197A AU 4326197 A AU4326197 A AU 4326197A AU 43261/97 A AU43261/97 A AU 43261/97A AU 4326197 A AU4326197 A AU 4326197A AU 4326197 A AU4326197 A AU 4326197A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43261/97A
Inventor
Yale B Mitchel
Jonathan A. Tobert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9617898.3A external-priority patent/GB9617898D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU4326197A publication Critical patent/AU4326197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
AU43261/97A 1996-07-09 1997-07-03 Pharmaceutical compositions Abandoned AU4326197A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US2142096P 1996-07-09 1996-07-09
US60021420 1996-07-09
GBGB9617898.3A GB9617898D0 (en) 1996-08-28 1996-08-28 Method for treating homozygous familial hypercholesterolemia
GB9617898 1996-08-28
US2935196P 1996-10-31 1996-10-31
US60029351 1996-10-31
PCT/US1997/010867 WO1998001119A2 (en) 1996-07-09 1997-07-03 Pharmaceutical compositions comprising simvastatin

Publications (1)

Publication Number Publication Date
AU4326197A true AU4326197A (en) 1998-02-02

Family

ID=27268450

Family Applications (3)

Application Number Title Priority Date Filing Date
AU36672/97A Abandoned AU3667297A (en) 1996-07-09 1997-07-03 Therapy for combined hyperlipidemia
AU42289/97A Abandoned AU4228997A (en) 1996-07-09 1997-07-03 Method for treating homozygous familial hypercholesterolemia
AU43261/97A Abandoned AU4326197A (en) 1996-07-09 1997-07-03 Pharmaceutical compositions

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AU36672/97A Abandoned AU3667297A (en) 1996-07-09 1997-07-03 Therapy for combined hyperlipidemia
AU42289/97A Abandoned AU4228997A (en) 1996-07-09 1997-07-03 Method for treating homozygous familial hypercholesterolemia

Country Status (2)

Country Link
AU (3) AU3667297A (en)
WO (3) WO1998001100A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030212996A1 (en) * 1996-02-08 2003-11-13 Wolzien Thomas R. System for interconnection of audio program data transmitted by radio to remote vehicle or individual with GPS location
IL141953A0 (en) * 1998-09-30 2002-03-10 Warner Lambert Co Method for preventing or delaying catheter-based revascularization
KR100590342B1 (en) 2001-03-28 2006-06-15 쉐링 코포레이션 Enantioselective synthesis of azetidinone intermediate compounds
AU2002358468A1 (en) * 2001-12-21 2003-07-15 Rigshospitalet Igamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux
AR040588A1 (en) 2002-07-26 2005-04-13 Schering Corp PHARMACEUTICAL FORMULATION INCLUDING AN INHIBITOR OF CHOLESTEROL ABSORPTION AND AN INHIBITOR OF A HMGCO TO REDUCTASE
JOP20080381B1 (en) 2007-08-23 2023-03-28 Amgen Inc Antigen Binding Proteins to Proprotein Convertase subtillisin Kexin type 9 (pcsk9)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806564A (en) * 1987-05-26 1989-02-21 Merck & Co., Inc. Antihypercholesterolemic beta-lactones
US4997849A (en) * 1989-06-23 1991-03-05 Merck & Co., Inc. Microbial transformation of simvastatin
US5393893A (en) * 1993-11-08 1995-02-28 Apotex, Inc. Process for producing simvastatin and analogs thereof

Also Published As

Publication number Publication date
WO1998001119A2 (en) 1998-01-15
AU4228997A (en) 1998-02-02
WO1998001100A2 (en) 1998-01-15
WO1998001100A3 (en) 1998-02-12
WO1998001116A1 (en) 1998-01-15
AU3667297A (en) 1998-02-02

Similar Documents

Publication Publication Date Title
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
AU6216296A (en) Pharmaceutical compositions
AU3049397A (en) Cyclosporin-containing pharmaceutical composition
AU6740298A (en) Pharmaceutical composition
AU5136998A (en) Medicinal composition
AU8107998A (en) Pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
AU5157898A (en) Hnf3delta compositions
GB9610359D0 (en) Pharmaceutical compositions
AU5274096A (en) Pharmaceutical compositions
AU2531295A (en) Pharmaceutical composition
AU9343098A (en) Pharmaceutical composition
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
GB9622681D0 (en) Pharmaceutical compositions
AU3460897A (en) Medicinal compositions
GB9613457D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
AU4326197A (en) Pharmaceutical compositions
AU4457597A (en) Pharmaceutical compositions
AU2087897A (en) Pharmaceutical compositions
AU1427895A (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions